Compare · BIMI vs CAH
BIMI vs CAH
Side-by-side comparison of BIMI International Medical Inc. (BIMI) and Cardinal Health Inc. (CAH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both BIMI and CAH operate in Other Pharmaceuticals (Health Care), so they compete in similar markets.
- CAH is the larger of the two at $55.33B, about 3979.1x BIMI ($13.9M).
- CAH has hit the wire 30 times in the past 4 weeks while BIMI has been quiet.
- CAH has more recent analyst coverage (25 ratings vs 0 for BIMI).
- Company
- BIMI International Medical Inc.
- Cardinal Health Inc.
- Price
- -
- -
- Market cap
- $13.9M
- $55.33B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Other Pharmaceuticals
- Other Pharmaceuticals
- Exchange
- NASDAQ
- NYSE
- IPO
- News (4w)
- 0
- 30
- Recent ratings
- 0
- 25
BIMI International Medical Inc.
BOQI International Medical Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical devices, and pharmaceutical and other healthcare products in the People's Republic of China. It offers prescription and over-the-counter drugs, nutritional supplements, health foods, and sundry products, as well as traditional Chinese medicines, personal and family care products, and miscellaneous items under the Lijiantang Pharmacy brand name. The company also provides IT research and development services. It sells its medicine and other healthcare products to customers through its directly owned stores. The company was formerly known as NF Energy Saving Corporation and changed its name to BOQI International Medical Inc. in December 2019. BOQI International Medical Inc. was incorporated in 2000 and is based in Dalian, the People's Republic of China.
Cardinal Health Inc.
Cardinal Health, Inc. operates as an integrated healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. The company operates in two segments, Pharmaceutical and Medical. The Pharmaceutical segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The segment also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; operates nuclear pharmacies and radiopharmaceutical manufacturing facilities; repackages generic pharmaceuticals and over-the-counter healthcare products; and offers medication therapy management and patient outcomes services to hospitals, other healthcare providers, and payers, as well as provides pharmacy management services to hospitals. The Medical segment manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe and sharps disposals; compressions; incontinences; nutritional delivery products; wound care products; single-use surgical drapes, gowns, and apparels; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. The segment also distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile, and non-sterile procedure kits. Cardinal Health, Inc. was founded in 1979 and is headquartered in Dublin, Ohio.
Latest BIMI
- BIMI International Medical Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
- 12 Health Care Stocks Moving In Wednesday's After-Market Session
- Why Ovid Therapeutics Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- Why Nurix Therapeutics Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Why AMMO Shares Are Trading Lower By Over 19%? Here Are Other Stocks Moving In Friday's Mid-Day Session
- Director Oudom Fnu was granted 1,123,500 shares, increasing direct ownership by 285% to 1,518,243 units (SEC Form 4)
- BIMI International Medical Inc. filed SEC Form 8-K: Leadership Update
- 12 Health Care Stocks Moving In Monday's After-Market Session
- BIMI International Medical Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Financial Statements and Exhibits
Latest CAH
- Chief Accounting Officer Scherer Mary C. sold $546,473 worth of shares (2,302 units at $237.39), decreasing direct ownership by 45% to 2,811 units (SEC Form 4)
- Chief Executive Officer Hollar Jason M. sold $29,375,516 worth of shares (124,529 units at $235.89), decreasing direct ownership by 40% to 190,603 units (SEC Form 4)
- CEO, GMPD Segment Mason Stephen M sold $8,274,117 worth of shares (35,000 units at $236.40), decreasing direct ownership by 66% to 18,061 units (SEC Form 4)
- CEO, PSS Segment Weitzman Deborah sold $1,731,524 worth of shares (7,354 units at $235.45), decreasing direct ownership by 9% to 77,901 units (SEC Form 4)
- Chief Financial Officer Alt Aaron E sold $9,926,140 worth of shares (42,000 units at $236.34), decreasing direct ownership by 67% to 20,495 units (SEC Form 4)
- Chief Legal/Compliance Officer Mayer Jessica L sold $6,952,485 worth of shares (29,436 units at $236.19), decreasing direct ownership by 47% to 33,076 units (SEC Form 4)
- Chief Information Officer Greene Michelle D. sold $2,746,187 worth of shares (11,650 units at $235.72), decreasing direct ownership by 53% to 10,330 units (SEC Form 4)
- RBC Capital Mkts initiated coverage on Cardinal Health with a new price target
- CEO, PSS Segment Weitzman Deborah was granted 7,314 shares and covered exercise/tax liability with 29,759 shares, decreasing direct ownership by 21% to 85,255 units (SEC Form 4) (for tax liability)
- CEO, GMPD Segment Mason Stephen M was granted 5,868 shares and covered exercise/tax liability with 25,289 shares, decreasing direct ownership by 27% to 53,061 units (SEC Form 4) (tax liability)